{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:29:58Z","timestamp":1792873798546,"version":"4.5.0"},"reference-count":51,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2020,3,1]]},"DOI":"10.1001\/jamapsychiatry.2019.3655","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T16:35:52Z","timestamp":1576082152000},"page":"246","source":"Crossref","is-referenced-by-count":139,"title":["Effects of Mirtazapine for Methamphetamine Use Disorder Among Cisgender Men and Transgender Women Who Have Sex With Men"],"prefix":"10.1001","volume":"77","author":[{"given":"Phillip O.","family":"Coffin","sequence":"first","affiliation":[{"name":"San Francisco Department of Public Health, San Francisco, California"},{"name":"Department of Medicine, University of California, San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn-Milo","family":"Santos","sequence":"additional","affiliation":[{"name":"San Francisco Department of Public Health, San Francisco, California"},{"name":"School of Nursing, University of California, San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaclyn","family":"Hern","sequence":"additional","affiliation":[{"name":"San Francisco Department of Public Health, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Vittinghoff","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Walker","sequence":"additional","affiliation":[{"name":"San Francisco Department of Public Health, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Matheson","sequence":"additional","affiliation":[{"name":"San Francisco Department of Public Health, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre","family":"Santos","sequence":"additional","affiliation":[{"name":"San Francisco Department of Public Health, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Colfax","sequence":"additional","affiliation":[{"name":"San Francisco Department of Public Health, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Batki","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of California, San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"yoi190079r4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/02791072.2003.10400511","article-title":"Psychiatric and substance dependence comorbidities, sexually transmitted diseases, and risk behaviors among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment.","volume":"35","author":"Shoptaw","year":"2003","journal-title":"J Psychoactive Drugs"},{"issue":"8","key":"yoi190079r5","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/archsurg.139.8.844","article-title":"Toll of methamphetamine on the trauma system.","volume":"139","author":"Tominaga","year":"2004","journal-title":"Arch Surg"},{"issue":"47","key":"yoi190079r6","first-page":"882","article-title":"Increasing morbidity and mortality associated with abuse of methamphetamine\u2014United States, 1991-1994.","volume":"44","author":"Centers for Disease Control and Prevention (CDC)","year":"1995","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"yoi190079r7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/01.yco.0000165592.52811.84","article-title":"Emerging research on methamphetamine.","volume":"18","author":"Maxwell","year":"2005","journal-title":"Curr Opin Psychiatry"},{"issue":"4","key":"yoi190079r9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jsat.2005.08.012","article-title":"Methamphetamine treatment: trends and predictors of retention and completion in a large state treatment system (1992-2002).","volume":"29","author":"Brecht","year":"2005","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"yoi190079r10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/10673220591003605","article-title":"Implications of chronic methamphetamine use: a literature review.","volume":"13","author":"Meredith","year":"2005","journal-title":"Harv Rev Psychiatry"},{"issue":"2","key":"yoi190079r11","first-page":"125","article-title":"Meth mouth: a review of methamphetamine abuse and its oral manifestations.","volume":"54","author":"Curtis","year":"2006","journal-title":"Gen Dent"},{"issue":"3","key":"yoi190079r12","first-page":"189","article-title":"Etiology of xerostomia and dental caries among methamphetamine abusers.","volume":"3","author":"Saini","year":"2005","journal-title":"Oral Health Prev Dent"},{"issue":"4","key":"yoi190079r13","first-page":"32","article-title":"Methamphetamine and meth mouth: an overview.","volume":"86","author":"Williams","year":"2006","journal-title":"J Tenn Dent Assoc"},{"issue":"1-3","key":"yoi190079r15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.drugalcdep.2009.02.002","article-title":"Factors associated with event-level stimulant use during sex in a sample of older, low-income men who have sex with men in Los Angeles.","volume":"102","author":"Ober","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"yoi190079r16","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1007\/s10508-007-9206-z","article-title":"Associations between crystal methamphetamine use and potentially unsafe sexual activity among gay men in Australia.","volume":"36","author":"Rawstorne","year":"2007","journal-title":"Arch Sex Behav"},{"issue":"10","key":"yoi190079r17","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1080\/10826080701212519","article-title":"Amphetamine use and sexual risk among men who have sex with men: results from the National HIV Behavioral Surveillance study\u2014New York City.","volume":"42","author":"Koblin","year":"2007","journal-title":"Subst Use Misuse"},{"issue":"1","key":"yoi190079r18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/QAI.0b013e3180417c99","article-title":"The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study.","volume":"45","author":"Plankey","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"yoi190079r19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1258\/095646207779949709","article-title":"Methamphetamine use and sexual risk behaviours among men who have sex with men diagnosed with early syphilis in Los Angeles County.","volume":"18","author":"Taylor","year":"2007","journal-title":"Int J STD AIDS"},{"issue":"4","key":"yoi190079r20","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s10508-007-9292-y","article-title":"Sexual marathons and methamphetamine use among HIV-positive men who have sex with men.","volume":"38","author":"Semple","year":"2009","journal-title":"Arch Sex Behav"},{"issue":"6","key":"yoi190079r21","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/bcp.2010.69.issue-6","article-title":"Pharmacological approaches to methamphetamine dependence: a focused review.","volume":"69","author":"Karila","year":"2010","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"yoi190079r22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1151\/ascp","article-title":"The search for medications to treat stimulant dependence.","volume":"4","author":"Kampman","year":"2008","journal-title":"Addict Sci Clin Pract"},{"issue":"5","key":"yoi190079r23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1080\/13543784.2017.1313229","article-title":"Pharmacotherapeutic agents in the treatment of methamphetamine dependence.","volume":"26","author":"Morley","year":"2017","journal-title":"Expert Opin Investig Drugs"},{"issue":"5","key":"yoi190079r24","doi-asserted-by":"publisher","first-page":"358","DOI":"10.4088\/JCP.v62n0509","article-title":"Does mirtazapine have a more rapid onset than SSRIs?","volume":"62","author":"Quitkin","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"yoi190079r25","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1002\/(ISSN)1099-1077","article-title":"Tolerability and safety aspects of mirtazapine.","volume":"17","author":"Nutt","year":"2002","journal-title":"Hum Psychopharmacol"},{"issue":"17","key":"yoi190079r26","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1056\/NEJMra050730","article-title":"The medical management of depression.","volume":"353","author":"Mann","year":"2005","journal-title":"N Engl J Med"},{"issue":"1-3","key":"yoi190079r27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejphar.2004.01.018","article-title":"Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex.","volume":"487","author":"Devoto","year":"2004","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"yoi190079r28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.brainresbull.2004.02.007","article-title":"Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation.","volume":"63","author":"Nakayama","year":"2004","journal-title":"Brain Res Bull"},{"issue":"3","key":"yoi190079r29","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0165-0327(98)00223-7","article-title":"Acute and long-term actions of the antidepressant drug mirtazapine on central 5-HT neurotransmission.","volume":"51","author":"Haddjeri","year":"1998","journal-title":"J Affect Disord"},{"issue":"11","key":"yoi190079r30","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1001\/archgenpsychiatry.2011.124","article-title":"Mirtazapine to reduce methamphetamine use: a randomized controlled trial.","volume":"68","author":"Colfax","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"yoi190079r34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1017\/S0141347300006583","article-title":"Motivational interviewing with problem drinkers.","volume":"11","author":"Miller","year":"1983","journal-title":"Behav Psychother"},{"key":"yoi190079r35","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/BF01204849","article-title":"Self-efficacy and the stages of self change in smoking.","volume":"9","author":"DiClemente","year":"1985","journal-title":"Cognit Ther Res"},{"issue":"6","key":"yoi190079r36","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1007\/s10461-010-9799-4","article-title":"Real-time adherence monitoring for HIV antiretroviral therapy.","volume":"14","author":"Haberer","year":"2010","journal-title":"AIDS Behav"},{"issue":"10","key":"yoi190079r38","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3928\/0048-5713-19981001-08","article-title":"Craving and withdrawal symptoms for various drugs of abuse.","volume":"28","author":"Mezinskis","year":"1998","journal-title":"Psychiatr Ann"},{"issue":"3","key":"yoi190079r39","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0376-8716(00)00217-9","article-title":"Craving predicts use during treatment for methamphetamine dependence: a prospective, repeated-measures, within-subject analysis.","volume":"63","author":"Hartz","year":"2001","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"yoi190079r40","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1017\/S0033291700048017","article-title":"The brief symptom inventory: an introductory report.","volume":"13","author":"Derogatis","year":"1983","journal-title":"Psychol Med"},{"issue":"5","key":"yoi190079r41","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1046\/j.1360-0443.1995.9056072.x","article-title":"The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users.","volume":"90","author":"Gossop","year":"1995","journal-title":"Addiction"},{"issue":"3","key":"yoi190079r42","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0022-3999(02)00604-9","article-title":"The diagnostic validity of the Athens Insomnia Scale.","volume":"55","author":"Soldatos","year":"2003","journal-title":"J Psychosom Res"},{"issue":"4","key":"yoi190079r43","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/(ISSN)1099-1166","article-title":"Factorial structure of a short version of the Center for Epidemiologic Studies Depression Scale.","volume":"21","author":"Cheng","year":"2006","journal-title":"Int J Geriatr Psychiatry"},{"issue":"14","key":"yoi190079r44","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/(ISSN)1097-0258","article-title":"A simple method of sample size calculation for linear and logistic regression.","volume":"17","author":"Hsieh","year":"1998","journal-title":"Stat Med"},{"issue":"5","key":"yoi190079r45","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/cns.2012.18.issue-5","article-title":"A novel, nonbinary evaluation of success and failure reveals bupropion efficacy versus methamphetamine dependence: reanalysis of a multisite trial.","volume":"18","author":"McCann","year":"2012","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"yoi190079r47","doi-asserted-by":"crossref","DOI":"10.5812\/ijhrba.23903","article-title":"Effect of abstinence on depression, anxiety, and quality of life in chronic methamphetamine users in a therapeutic community.","volume":"4","author":"Bagheri","year":"2015","journal-title":"Int J High Risk Behav Addict"},{"issue":"4","key":"yoi190079r48","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/NMD.0b013e31819db6fe","article-title":"Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up.","volume":"197","author":"Glasner-Edwards","year":"2009","journal-title":"J Nerv Ment Dis"},{"issue":"2","key":"yoi190079r49","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.psychres.2014.05.026","article-title":"The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disorders.","volume":"219","author":"Mahoney","year":"2014","journal-title":"Psychiatry Res"},{"issue":"3","key":"yoi190079r50","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jsat.2007.12.003","article-title":"Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: a comparison of mirtazapine and modafinil with treatment as usual.","volume":"35","author":"McGregor","year":"2008","journal-title":"J Subst Abuse Treat"},{"issue":"8","key":"yoi190079r51","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1086\/cid.2001.33.issue-8","article-title":"Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring.","volume":"33","author":"Arnsten","year":"2001","journal-title":"Clin Infect Dis"},{"key":"yoi190079r31","volume-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders\u2014Non-Patient Edition (SCID-I\/NP, 1\/2007 revision)","author":"First","year":"2007"},{"key":"yoi190079r32","volume-title":"Relapse Prevention Treatment for Cocaine Addiction: the RPT-C Manual","author":"Brief","year":"1998"},{"key":"yoi190079r33","volume-title":"Motivational Interviewing","author":"Miller","year":"2002","edition":"2nd ed"},{"key":"yoi190079r1","unstructured":"United Nations Office on Drugs and Crime. World drug report 2015. https:\/\/www.unodc.org\/documents\/wdr2015\/World_Drug_Report_2015.pdf. Published 2015. Accessed October 21. 2019."},{"key":"yoi190079r2","unstructured":"AhrnsbrakR, BoseJ, HeddenSL, LipariRN, Park-LeeE. Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the united states: results from the 2016 National Survey on Drug Use and Health (HHS Publication No. SMA 17-5044, NSDUH Series H-52). https:\/\/www.samhsa.gov\/data\/report\/key-substance-use-and-mental-health-indicators-united-states-results-2016-national-survey. Published 2017. Accessed October 21, 2019."},{"key":"yoi190079r3","unstructured":"CoffinPO. National drug early warning system (NDEWS) San Francisco sentinel community site drug use patterns and trends, 2016. https:\/\/ndews.umd.edu\/sites\/ndews.umd.edu\/files\/u1424\/san_francisco_scs_drug_use_patterns_and_trends_2016.pdf. Published 2016. Accessed October 21, 2019."},{"key":"yoi190079r8","unstructured":"U.S. Department of Health & Human Services Substance Use and Mental Health Services Administration. Amphetamine and methamphetamine emergency department visits, 1995-2002. http:\/\/citeseerx.ist.psu.edu\/viewdoc\/download?doi=10.1.1.187.6444&rep=rep1&type=pdf. Published July 2004. Accessed February 22, 2007."},{"key":"yoi190079r14","unstructured":"NicosiaN, PaculaRL, KilmerB, LundbergR, ChiesaJ. The economic cost of methamphetamine use in the United States, 2005. https:\/\/www.rand.org\/pubs\/monographs\/MG829.html. Published 2009. Accessed November 5, 2009."},{"key":"yoi190079r37","unstructured":"Division of AIDS\u2014National Institute of Allergy and Infectious Diseases. Division of AIDS (DAIDS) table for grading the severity of adult and pediatric adverse events. https:\/\/rsc.niaid.nih.gov\/sites\/default\/files\/daidsgradingcorrectedv21.pdf. Published 2009. Accessed October 21, 2019."},{"key":"yoi190079r46","unstructured":"United Nations AIDS Program. Undetectable=untransmissible: public health and viral load suppression. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/undetectable-untransmittable_en.pdf. Published 2018. Accessed November 1, 2019."}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2757018\/jamapsychiatry_coffin_2019_oi_190079.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T16:01:43Z","timestamp":1583337703000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2757018"}},"subtitle":["A Placebo-Controlled Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2019.3655","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,1]]}}}